Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method

  • A Espinel-Ingroff
  • , A Chowdhary
  • , G M Gonzalez
  • , J Guinea
  • , F Hagen
  • , J F Meis
  • , G R Thompson
  • , J Turnidge

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Epidemiological cutoff values (ECVs) of isavuconazole are not available for Cryptococcus spp. The isavuconazole ECVs based on wild-type (WT) MIC distributions for 438 Cryptococcus neoformans nongenotyped isolates, 870 isolates of genotype VNI, and 406 Cryptococcus gattii isolates from six laboratories and different geographical areas were 0.06, 0.12, and 0.25 μg/ml, respectively. These ECVs may aid in detecting non-WT isolates with reduced susceptibilities to isavuconazole.

Original languageEnglish
Pages (from-to)666-8
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume59
Issue number1
DOIs
Publication statusPublished - Jan 2015
Externally publishedYes

Keywords

  • Antifungal Agents/pharmacology
  • Cryptococcosis/drug therapy
  • Cryptococcus gattii/drug effects
  • Cryptococcus neoformans/drug effects
  • Genotype
  • Humans
  • Microbial Sensitivity Tests
  • Nitriles/pharmacology
  • Pyridines/pharmacology
  • Triazoles/pharmacology

Fingerprint

Dive into the research topics of 'Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method'. Together they form a unique fingerprint.

Cite this